- Home
- ROIV vs THC Comparison
ROIV vs THC Comparison
Compare ROIV & THC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | THC |
|---|---|---|
| Founded | 2014 | 1967 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 17.6B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ROIV | THC |
|---|---|---|
| Price | $27.08 | $179.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 21 |
| Target Price | $28.94 | ★ $237.90 |
| AVG Volume (30 Days) | ★ 4.5M | 1.0M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 15.49 |
| Revenue | $29,053,000.00 | ★ $18,479,000,000.00 |
| Revenue This Year | N/A | $4.36 |
| Revenue Next Year | $744.61 | $1.89 |
| P/E Ratio | ★ N/A | $12.10 |
| Revenue Growth | N/A | ★ 0.91 |
| 52 Week Low | $10.58 | $121.83 |
| 52 Week High | $30.33 | $247.21 |
Technical Indicators
Market Signals| Indicator | ROIV | THC |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 35.13 |
| Support Level | $26.94 | $146.60 |
| Resistance Level | $27.94 | $185.25 |
| Average True Range (ATR) | 0.85 | 7.94 |
| MACD | -0.12 | -0.12 |
| Stochastic Oscillator | 14.42 | 27.80 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About THC Tenet Healthcare Corporation
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.